- Filed
- Jun 8, 2026 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Jun 8, 2026 | 423.08M sh |
| Stock Issued | Q1 2025 · Mar 31, 2025 | 500K sh |
| Stock Issued | Q1 2025 · Feb 10, 2022 | 96.78M sh |
| Stock Issued | Q1 2025 · Oct 5, 2021 | 500K sh |
| Stock Issued restated | Q1 2025 · Feb 15, 2019 | 2.97M sh |
| Cash And Equivalents restated | Q1 2025 · Mar 31, 2025 | $19.88M |
| Cash And Equivalents restated | Q1 2025 · Dec 31, 2024 | $25.38M |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2025 | $7.67M |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2024 | $6.45M |
| Current Liabilities restated | Q1 2025 · Mar 31, 2025 | $21.38M |
| Current Liabilities restated | Q1 2025 · Dec 31, 2024 | $26.25M |
| Total Liabilities restated | Q1 2025 · Mar 31, 2025 | $22.39M |
| Total Liabilities restated | Q1 2025 · Dec 31, 2024 | $27.3M |
| Current Assets restated | Q1 2025 · Mar 31, 2025 | $23.33M |
| Current Assets restated | Q1 2025 · Dec 31, 2024 | $27.24M |
| Total Assets restated | Q1 2025 · Mar 31, 2025 | $30.07M |
| Total Assets restated | Q1 2025 · Dec 31, 2024 | $33.77M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 389.08M sh |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | $7.76M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.00 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $2.23M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $0 |
| Net Income restated | Q1 2025 · Mar 31, 2024 | $901.55K |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $28.56K |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $2.34M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $4.03M |
| Revenue | Q1 2025 · Mar 31, 2024 | $6.38M |